TCG Crossover Management »

Maze Therapeatics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.2M 174k 41.43

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cogent Biosciences Comm (COGT)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Centessa Pharmaceuticals Adrs (CNTA)
Dyne Therapeutics Comm (DYN)
Rapt Therapeutics Comm (RAPT)
Tyra Biosciences Comm (TYRA)
Amylyx Pharmaceuticals Comm (AMLX)
Savara Comm (SVRA)
Monte Rosa Therapeutics Comm (GLUE)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Eyepoint Pharmaceuticals Comm (EYPT)
Structure Therapeutics Adrs (GPCR)

View all positions for TCG Crossover Management

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Deep Track Capital
Arch Venture Corp
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Alphabet
General Catalyst Group Management
Woodline Partners
TRV GP V
Logos Global Management
Bellevue Group
Marshall Wace

View all funds holding Maze Therapeatics